Molecular profile of osteoprogenitor cells seeded on allograft bone

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 9, 2011, Pages 704-711

  Smith, Kierann E ^a   Huang, Zhinong ^a   Ma, Ting ^a   Irani, Afraaz ^a   Lane Smith, R ^a   Goodman, Stuart B ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Allograft bone; Bone scaffold; Growth factors; Molecular profile; Osteoprogenitor cells; Transcription factors

Indexed keywords

CYTOLOGY; POLYMERASE CHAIN REACTION; SCAFFOLDS (BIOLOGY); TRANSCRIPTION; TRANSCRIPTION FACTORS;

ALLOGRAFT BONE; BONE FORMATION; BONE SCAFFOLDS; EXPRESSION PATTERNS; GROWTH FACTOR; MOLECULAR PROFILE; OSTEOCALCIN; OSTEOPROGENITOR CELLS; PROTEIN LEVEL; TGF-Β1;

BONE;

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BONE ALLOGRAFT; BONE DENSITY; BONE DEVELOPMENT; BONE GROWTH; BONE MARROW CELL; BONE MARROW CULTURE; BONE MATURATION; BONE MINERALIZATION; CANCELLOUS BONE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPROGENITOR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 80053140116     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.367     Document Type: Article

References (48)

1. An HS, Thonar EJ, Masuda K. 2003; Biological repair of intervertebral disc. Spine 28: S86.
2. Antosz ME, Bellows CG, Aubin JE. 1989; Effects of transforming growth factor beta and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells, J Cell Physiol 140: 386-395.
3. Arrington ED, Smith WJ, Chambers HG, et al. 1996; Complications of iliac crest bone graft harvesting. Clin Orthop 329: 300-309.
4. Ber R, Kubota T, Sodek J, et al. 1991; Effects of transforming growth factor-β on normal clonal bone cell populations. Biochem Cell Biol 69: 132-140.
5. Bishop GB, Einhorn TA. 2007; Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 6: 721-727.
6. Burchardt H. 1983; The biology of bone graft repair. Clin Orthop Relat Res 174: 28-42.
7. Burchardt H. 1987; Biology of bone transplantation. Orthop Clin North Am 18(2): 187-196.
8. Canalis E. 2007; Skeletal growth factors. In Osteoporosis, 3rd edn, Marcus R, Feldman D, Nelson D, Rosen C (eds). Academic Press: San Diego, CA, USA; 529-546.
9. Canalis E. 2009; Growth factor control of bone mass. J Cell Biochem 108(4): 769-777.
10. Chen M, Zhu M, Awad H, et al. 2008; Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci 121(9): 1455-1465.
11. Chiu R, Ma T, Smith RL, et al. 2006; Polymethylmethacrylate particles inhibit osteoblastic differentiation of bone marrow osteoprogenitor cells. J Biomed Mater Res A 77(4): 850-856.
12. Cho TJ, Gerstenfeld LC, Einhorn TA. 2002; Differential temporal expression of members of the transforming growth factor-β superfamily during murine fracture healing. J Bone Miner Res 17: 513-520.
13. Ebeling PR, Jones JD, O'Fallon WM, et al. 1993; Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77: 1384-1387.
14. Eswarakumar VP, Monsonego-Ornan E, Pines M, et al. 2002; The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129: 3783-3793.
15. Flory MR, Lee H, Bonneau R, et al. 2006; Quantitative proteomic analysis of the budding yeast cell cycle using acid-cleavable isotope-coded affinity tag reagents. Proteomics 6(23): 6146-6157.
16. Fowler BL, Dall BE, Rowe DE. 1995; Complications associated with harvesting autogenous iliac bone graft. Am J Orthop 12: 895-903.
17. Gazdag AR, Lane JM, Glaser D, et al. 1995; Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 1: 1-8.
18. Globus RK, Plouet J, Gospodarowicz D. 1989; Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124: 1539-1547.
19. Gnecchi M, Melo LG. 2009; Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 482: 281-294.
20. Goulet JA, Senunas LE, DeSilva GL, et al. 1997; Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop 339: 76-81.
21. Griffin TJ, Gygi SP, Ideker T, et al. 2002; Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteom 1(4): 323-333.
22. Hering S, Isken E, Knabbe C, et al. 2001; TGFβ 1 and TGFβ 2 mRNA and protein expression in human bone samples Exp Clin Endocrinol Diabetes 109: 217-226.
23. Huang YC, Kaigler D, Rice KG, et al. 2005; Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20(5): 848-857.
24. Huang Z, Nelson ER, Smith RL, et al. 2007; The sequential expression profiles of growth factors from osteoprogenitors to osteoblasts in vitro. Tissue Eng 13: 2311-2320.
25. Kubota T, Zhang Q, Wrana JL, et al. 1989; Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGFβ. Biochem Biophys Res Commun 162: 1453-1459.
26. Lamerigts NM, Buma P, Aspenberg P, et al. 1999; Role of growth factors in the incorporation of unloaded bone allografts in the goat. Clin Orthop 368: 260-270.
27. Laurencin CT. 2003; Bone Graft Substitutes. ASTM International: West Conshohocken, PA, USA.
28. Marom R, Shur I, Solomon R, et al. 2005; Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol 202(1): 41-48.
29. Masuda K, An HS. 2004; Growth factors and the intervertebral disc. Spine J 4: 330S.
30. Meirelles Lda S, Nardi NB. 2003; Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion and characterization. Br J Haematol 4: 702-711.
31. Nelson ER, Huang Z, Ma T, et al. 2008; New bone formation by murine osteoprogenitor cells cultured on corticocancellous allograft bone. J Orthop Res 12: 1660-1664.
32. Pelton RW, Saxena B, Jones M, et al. 1991; Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091-1105.
33. Robey PG, Young MF, Flanders KC, et al. 1987; Osteoblasts synthesize and respond to transforming growth factor-type β (TGFβ) in vitro. J Cell Biol 105: 457-463.
34. Rosen CJ. 2004; Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 18: 423-435.
35. Thorén K, Liung P, Pettersson H, et al. 1993; Comparison of talonavicular dowel arthrodesis utilizing autogenous bone versus defatted bank bone. Foot Ankle 14(3): 125-128.
36. Tian Q, Stepaniants SB, Mao M, et al. 2004; Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteom 3(10): 960-969.
37. Tropel P, Noël D, Platet N, et al. 2004; Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow Exp Cell Res 295(2): 395-406.
38. Tsuji H, Cawthorne C, Ecarot B. 1996; Abnomal modulation of serum osteocalcin by dietary phosphate and 1, 25-dihydroxyvitamin D3 in the hypophosphatemic mouse. J Bone Miner Res 11: 1234-1240.
39. Urist MR. 1965; Bone: formation by autoinduction. Science 150: 893.
40. Varkey M, Kucharski C, Haque T, et al. 2006; In vitro osteogenic response of rate bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Rel Res 443: 113.
41. Vonau RI, Bostrum MP, Aspenberg P, et al. 2001; Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop 386: 243-251.
42. Wang JS, Aspenberg P. 1996; Basic fibroblast growth factor infused at different times during bone graft incorporation. Titanium chamber study in rats. Acta Orthop Scand 67(3): 229-236.
43. Wang D. 2008; Discrepancy between mRNA and protein abundance: insight from information retrieval process in computers. Comput Biol Chem 32(6): 462-468.
44. Weiss S, Zimmermann G, Pufe T, et al. 2009; The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg 129(7): 989-997.
45. Wenstrup RJ, Fowlkes JL, Witte DP, et al. 1996; Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrix. J Biol Chem 271: 10271-10276.
46. Wohl GR, Towler DA, Silva MJ. 2009; Stress fracture healing: fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair. Bone 44(2): 320-330.
47. Younger EM, Chapman MW. 1989; Morbidity at bone graft donor sites. J Orthop Trauma 3: 192-195.
48. Zhang X, Awad HA, O'Keefe RJ, et al. 2008; A perspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res 466(8): 1777-1787 (review; Epub 29 May 2008).